DOW JONES, A NEWS CORP COMPANY
Sections
Aim higher, reach further.
Get the Wall Street Journal $12 for 12 weeks. Subscribe Now

Clinton Foundation Sets Up Malaria-Drug Price Plan

Aim Is to Stabilize Fluctuating Prices, Boost Availability

Former President Bill Clinton's foundation is set to unveil a pricing agreement Thursday that it hopes will make malaria drugs available to millions of poor people.

The agreement points to the sophistication needed to harness market forces and get lifesaving medicines to countries where treatable diseases still take a staggering toll.

First-line malaria drugs -- known as ACTs, for artemisinin-based combination therapies --...

Popular on WSJ

Editors’ Picks